GlassScriptPhysician profile
Vitaliya Boyar
NPI 1356508766
$88,264.20
in general payments reported to CMS, 2019-2025
15 companies · $391 in 2025
The $391 reported for 2025 was more than what 88% of Neonatal-Perinatal Medicine providers received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $25K · 2021: $19K · 2022: $11K · 2023: $16K · 2024: $6,724 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Grant: $5,049 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,794 · Travel and Lodging: $1,455 · Food and Beverage: $451 · Education: $86.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,098.79 |
| Grant | $5,049.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,794.00 |
| Travel and Lodging | $1,455.24 |
| Food and Beverage | $450.59 |
| Education | $86.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $36,400.37 | 2019-2023 | |
| Urgo Medical North America, LLC | $12,829.18 | 2020-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Medline Industries LP | $8,169.65 | 2019-2021 | |
| Coloplast Corp | $8,130.00 | 2023 | Sensura Mio |
| Kerecis Limited | $6,504.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Sanara Medtech INC. | $5,164.00 | 2020-2021 | |
| Convatec INC. | $4,234.90 | 2019-2023 | |
| Kci USA, INC. | $2,989.48 | 2019-2021 | |
| Hydrofera LLC | $2,400.00 | 2021 | |
| Baxter Healthcare | $650.00 | 2019 | |
| Ony Biotech INC. | $364.75 | 2025 | Infasurf |
| Chiesi USA, INC. | $125.73 | 2024 | Curosurf |
| Organogenesis INC. | $112.51 | 2019 | |
| Mallinckrodt Enterprises LLC | $95.39 | 2019 | |
| Becton, Dickinson and Company | $94.00 | 2024 | Bd Nexiva, Bd Introsyte |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vitaliya Boyar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.